X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

FDA Finally Gives Nod To DxFLEX Clinical Flow Cytometer

Content Team by Content Team
13th March 2024
in Manufacturing, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

It is worth noting that Beckman Coulter Life Sciences, which happens to be a global leader within the laboratory automation as well as innovation, has gone on to receive 510 thousand clearances from the Food and Drug Administration- FDA so as to distribute its DxFLEX Clinical Flow Cytometer across the United States. Originally launched across the region in 2020, this advancement brings the popular benchtop IVD flow cytometry system to American labs while at the same time expand their testing capacities. Offering almost 13- colors, additional detectors can go on to get activated as the laboratory requirements go on to evolve sans the requirement to purchase more hardware.

The product manager, Carsten Lange, said that this pioneering development goes on to put high-complexity flow cytometry testing within reach of many more laboratories, and that too without the added expense. It is worth noting that the DxFLEX Clinical Flow Cytometer goes on to add more colors sans adding more issues and helps the laboratory staff to get greater confidence as far as the results are concerned while at the same time also streamlining workflows along with decreasing the manual steps. With more fluorescence parameters, labs can go on to get more out of the specimens and also avoid a tedious compensation scenario and the kind of burden that it goes on to place on lab staff.

Praised for its one-of-a-kind and superior sensitivity as well as resolution, the compact DxFLEX Flow Cytometer goes on to make multicolor flow cytometry less intricate by way of using avalanche photodiode- APD detector technology rather than the traditional photomultiplier tube- PMT technology. The usage of APD technology goes on to simplify the compensation procedures and, at the same time, delivers richer content analysis by way of having higher sensitivity in order to find dim populations. In comparison, running compensation within the conventional PMT flow cytometer goes on to involve quite significant hands-on time, even when traits such as auto-compensation setup happen to be available within the software.

Apparently, the dynamic compensation library goes ahead and also simplifies compensation setup, while at the same time being easy-to-learn. CytExpert software decreases labor time and helps work to commence right out of the box as far as novice users are concerned. The compact DxFLEX Flow Cytometer happens to be available in two configurations- a three-laser/10-color system and a three-laser/13-color configuration.

The DxFLEX Flow Cytometer is validated as an in vitro diagnostic device for 10-color immunophenotyping with ClearLLab 10C Reagent System and goes on to deliver the only FDA-cleared as well as CE-marked integrated leukemia and lymphoma solution that offers all components required, right from quality controls, preparation of samples, as well as antibody panels, to analysis software teamed with training material. This helps the workflows for diseases like chronic leukemia, acute leukemia, myeloma, myeloproliferative neoplasm, non-Hodgkin lymphoma, and myelodysplastic syndrome.

Apart from the United States, the DxFLEX Flow Cytometer is available across nations that accept the CE mark as the basis for their country-specific registration, such as those in Europe and also in China, India, as well as Japan.

Previous Post

Cell Therapy Production Automation Set To Be On The Horizon

Next Post

CPHI Japan 2024: Rising Tides manufacturing in Japan

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
CPHI Japan 2024: Rising Tides manufacturing in Japan

CPHI Japan 2024: Rising Tides manufacturing in Japan

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In